|
|
Blood, 1 May 2007, Vol. 109, No. 9, pp. 3998-4005.
Prepublished online as a Blood First Edition Paper on January 16, 2007; DOI 10.1182/blood-2006-08-041202.
Previous Article | Table of Contents | Next Article 
NEOPLASIA
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
Guang Jin1,
Yukari Yamazaki1,
Miki Takuwa1,
Tomoko Takahara1,
Keiko Kaneko1,
Takeshi Kuwata1,
Satoshi Miyata2, and
Takuro Nakamura1
1 Department of Carcinogenesis, The Cancer Institute, and
2 Bioinformatics Group, Genome Center, Japanese Foundation for Cancer Research, Tokyo, Japan
Cooperative activation of Meis1 and Hoxa9 perturbs myeloid differentiation and eventually leads myeloid progenitors to leukemia, yet it remains to be clarified what kinds of subsequent molecular processes are required for development of overt leukemia. To understand the molecular pathway in Hoxa9/Meis1-induced leukemogenesis, retroviral insertional mutagenesis was applied using retrovirus-mediated gene transfer. The mice that received Hoxa9/Meis1-transduced bone marrow cells developed acute myeloid leukemia (AML), and Trib1, Evi1, Ahi1, Rar , Pitpnb, and AK039950 were identified as candidate cooperative genes located near common retroviral integration sites. Trib1 and Evi1 were up-regulated due to retroviral insertions, and coexpression of these genes significantly accelerated the onset of Hoxa9/Meis1-induced AML, suggesting that Trib1 and Evi1 are the key collaborators. Furthermore, Trib1 by itself is a novel myeloid oncogene, enhancing phosphorylation of ERK, resulting in inhibition of apoptosis. These results demonstrate the importance of specific oncogene interaction in myeloid leukemogenesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Survival signaling in HoxA9/Meis1 AML
- Gang G. Wang and Mark P. Kamps
Blood 2007 109: 3619-3620.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
K. Miyazaki, N. Yamasaki, H. Oda, T. Kuwata, Y. Kanno, M. Miyazaki, Y. Komeno, J. Kitaura, Z.-i. Honda, S. Warming, et al.
Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia
Blood,
May 7, 2009;
113(19):
4702 - 4710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-F. Shen, Y.-L. Hu, L. Uttarwar, E. Passegue, and C. Largman
MicroRNA-126 Regulates HOXA9 by Binding to the Homeobox
Mol. Cell. Biol.,
July 15, 2008;
28(14):
4609 - 4619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Watanabe-Okochi, J. Kitaura, R. Ono, H. Harada, Y. Harada, Y. Komeno, H. Nakajima, T. Nosaka, T. Inaba, and T. Kitamura
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
Blood,
April 15, 2008;
111(8):
4297 - 4308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Wouters, M. A. Jorda, K. Keeshan, I. Louwers, C. A. J. Erpelinck-Verschueren, D. Tielemans, A. W. Langerak, Y. He, Y. Yashiro-Ohtani, P. Zhang, et al.
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1
Blood,
November 15, 2007;
110(10):
3706 - 3714.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|